Thursday, October 15, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 15, 2026

Warren Buffett returned 6,000,000% plus for investors over 60 years. Here are his 5 biggest wins and what to learn

View original at finance.yahoo.com
Warren Buffett returned 6,000,000% plus for investors over 60 years. Here are his 5 biggest wins and what to learn Warren Buffett's last day running Berkshire Hathaway was December 31, 2025 (1)…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • See's Candies gave us over $2 billion of pretax income from $25 million investment

    60% confidence
  • Tim Cook has made Berkshire Hathaway a lot more money than I ever have

    60% confidence
  • We own Coca-Cola, which is a wonderful business. And we own Apple, which is an even better business

    60% confidence
  • The best thing that happens to us is when a great company gets into temporary trouble

    60% confidence
  • We expect to hold these securities for a long time. Our favorite holding period is forever

    60% confidence
  • 99% of wealth showed up after he turned 56

    60% confidence
  • Berkshire shares have returned more than 6,000,000% since 1965

    60% confidence
  • Be fearful when others are greedy, and greedy when others are fearful

    60% confidence
  • Forget what you know about buying fair businesses at wonderful prices; instead, buy wonderful businesses at fair prices

    60% confidence
  • The stock market is a device for transferring money from the impatient to the patient

    60% confidence
  • Growth occurred every year, just as certain as birthdays with Coca-Cola

    60% confidence
  • Buffett was slipping back into the stone age for not wanting to pay $25,000 more for See's Candies

    60% confidence

Data points we hold from this source

Apple Podcasts · portfolio weight23 percent
Apple Podcasts · market value174 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com